Agios Pharmaceuticals Cash from Financing (TTM) Analysis

Agios Pharmaceuticals Inc (AGIO)

29.86 +0.43 (+1.46%) USD | NASDAQ | Apr 19, 11:51

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	5.433M
September 30, 2023	4.608M
June 30, 2023	3.913M
March 31, 2023	3.609M
December 31, 2022	2.35M
September 30, 2022	-16.26M
June 30, 2022	-268.43M
March 31, 2022	-771.82M
December 31, 2021	-765.77M
September 30, 2021	-746.60M
June 30, 2021	-492.17M
March 31, 2021	263.39M
December 31, 2020	261.52M
September 30, 2020	538.54M
June 30, 2020	538.43M
March 31, 2020	290.14M
December 31, 2019	289.61M
September 30, 2019	13.02M
June 30, 2019	16.91M
March 31, 2019	22.61M
December 31, 2018	546.02M
September 30, 2018	547.60M
June 30, 2018	545.70M

Date	Value
March 31, 2018	809.34M
December 31, 2017	285.11M
September 30, 2017	286.51M
June 30, 2017	444.42M
March 31, 2017	172.72M
December 31, 2016	169.78M
September 30, 2016	167.07M
June 30, 2016	6.017M
March 31, 2016	5.659M
December 31, 2015	6.373M
September 30, 2015	244.14M
June 30, 2015	242.34M
March 31, 2015	336.40M
December 31, 2014	335.16M
September 30, 2014	95.68M
June 30, 2014	219.54M
March 31, 2014	124.44M
December 31, 2013	123.88M
September 30, 2013	124.36M
June 30, 2013	0.16M
March 31, 2013	0.129M
December 31, 2012	0.142M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-771.82M

Minimum

Mar 2022

538.54M

Maximum

Sep 2020

-43.66M

Average

4.608M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks